Cargando...
Small Molecule Inhibitors Targeting the ‘Achilles’ Heel of Androgen Receptor Activity
Androgen ablation therapy remains the gold standard for the treatment of advanced prostate cancer, but unfortunately, it is not curative and eventually the disease will return as lethal castration-resistant prostate cancer (CRPC). There is mounting evidence supporting the concept that development of...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2011
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132148/ https://ncbi.nlm.nih.gov/pubmed/21285252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN_10-3398 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|